Compare FDBC & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FDBC | SMTI |
|---|---|---|
| Founded | 1902 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 313.1M | 313.5M |
| IPO Year | 2000 | 2008 |
| Metric | FDBC | SMTI |
|---|---|---|
| Price | $54.42 | $34.00 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $34.00 |
| AVG Volume (30 Days) | 13.4K | ★ 399.7K |
| Earning Date | 04-22-2026 | 05-12-2026 |
| Dividend Yield | ★ 3.87% | N/A |
| EPS Growth | ★ 35.00 | N/A |
| EPS | ★ 2.63 | N/A |
| Revenue | N/A | ★ $15,586,976.00 |
| Revenue This Year | N/A | $17.31 |
| Revenue Next Year | N/A | $12.48 |
| P/E Ratio | $21.19 | ★ N/A |
| Revenue Growth | N/A | ★ 32.47 |
| 52 Week Low | $39.87 | $16.05 |
| 52 Week High | $56.14 | $35.70 |
| Indicator | FDBC | SMTI |
|---|---|---|
| Relative Strength Index (RSI) | 60.77 | 80.05 |
| Support Level | $41.48 | $33.68 |
| Resistance Level | N/A | $34.33 |
| Average True Range (ATR) | 1.47 | 0.61 |
| MACD | 0.11 | -0.06 |
| Stochastic Oscillator | 74.89 | 96.27 |
Fidelity D & D Bancorp Inc is a bank holding company. Through its wholly-owned state chartered commercial bank subsidiary, The Fidelity Deposit and Discount Bank (the Bank), the company provides a full range of banking, trust and financial services to individuals, small businesses and corporate customers. Its primary market areas are Lackawanna, Luzerne and Northampton Counties, Pennsylvania. The company's primary deposit products are demand deposits and interest-bearing time, money market and savings accounts. The company's segments include: Commercial and Industrial, Commercial Real Estate, Consumer, Residential Real Estate, with the majority of revenue generating from the Commercial Real Estate segment.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.